Jul 22, 2016 - Pharma Industry Outlook: Fundamentals Remain Strong
Jul 19, 2016 - Johnson & Johnson's (JNJ) shares were up in pre-market trading with the company beating on all fronts and raising its guidance for 2016.
Jul 18, 2016 - Roche Holding AG (RHHBY) announced disappointing results from the phase III study on Gazyva.
Jul 18, 2016 - The Dow notched up heavy gains during an eventful week, boosted by multiple factors.
Jul 15, 2016 - Ultragenyx (RARE) announced top-line data from a pivotal phase III study on rhGUS for the treatment of mucopolysaccharidosis 7.
Jul 14, 2016 - Pfizer (PFE) announced findings from two pivotal phase III studies on crisaborole for the treatment of patients with mild-to-moderate atopic dermatitis.
Jul 13, 2016 - Pfizer Inc. (PFE) announced that the FDA has approved a label expansion of vaccine Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]).
Jul 13, 2016 - Sucampo Pharmaceuticals, Inc. (SCMP) announced that it will discontinue the development of its pipeline candidate, cobiprostone.
Jul 13, 2016 - Shire plc (SHPG) received a major boost when the FDA approved its ophthalmology drug Xiidra for the treatment of the signs and symptoms of dry eye disease in adults.
Jun 14, 2016 - Don't Make It Complicated, Own Drug Stocks